Epididymitis after prostate brachytherapy.
D000230:Adenocarcinoma / Q000150:complications / Q000532:radiotherapy*; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D001918:Brachytherapy / Q000009:adverse effects*; D016971:Citrobacter freundii; D015331:Cohort Studies; D004198:Disease Susceptibility; D004756:Enterobacteriaceae Infections / Q000188:drug therapy / Q000209:etiology; D004823:Epididymitis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology* / Q000382:microbiology; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000209:etiology; D006801:Humans; D015994:Incidence; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010165:Palladium / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000150:complications / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000453:epidemiology / Q000209:etiology*; D011868:Radioisotopes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012307:Risk Factors; D011795:Surveys and Questionnaires; D013997:Time Factors
D000900:Anti-Bacterial Agents; D007457:Iodine Radioisotopes; D011868:Radioisotopes; D010165:Palladium